Free Trial
NASDAQ:ONVO

Organovo (ONVO) Stock Price, News & Analysis

Organovo logo

About Organovo Stock (NASDAQ:ONVO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.66
$15.24
52-Week Range
N/A
Volume
243,634 shs
Average Volume
617,505 shs
Market Capitalization
$3.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organovo and its competitors with MarketBeat's FREE daily newsletter.

ONVO Stock News Headlines

Two new option listings and one option delisting on April 24th
A grave, grave error.
Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the key to unlocking technological breakthroughs we once thought were impossible. And it may just be the only thing capable of bringing America back from the brink of recession – despite Washington’s incompetence and addiction to reckless spending. That’s why Elon Musk, Jeff Bezos, Jensen Huang, and even Bill Gates are pouring billions into the infrastructure behind it.
Organovo announces VivoSim to carry forward 3D bioprinting, legacy tech
VivoSim to Carry Forward Organovo 3D Bioprinting
Organovo expects to meet requirements for continued listing on Nasdaq
See More Headlines

ONVO Stock Analysis - Frequently Asked Questions

Organovo Holdings, Inc. (NASDAQ:ONVO) posted its quarterly earnings results on Wednesday, February, 19th. The medical research company reported ($2.28) EPS for the quarter, topping the consensus estimate of ($2.52) by $0.24. The medical research company had revenue of $0.02 million for the quarter, compared to the consensus estimate of $0.05 million. Organovo had a negative net margin of 10,151.64% and a negative trailing twelve-month return on equity of 346.26%.

Organovo shares reverse split on Friday, March 21st 2025.The 1-12 reverse split was announced on Wednesday, March 19th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 20th 2025. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Shares of ONVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Organovo investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Brainstorm Cell Therapeutics (BCLI), AST SpaceMobile (ASTS) and Virgin Galactic (SPCE).

Company Calendar

Last Earnings
2/19/2025
Today
7/02/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ONVO
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.67 million
Net Margins
-10,151.64%
Pretax Margin
-10,150.00%

Debt

Sales & Book Value

Annual Sales
$122 thousand
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
N/A

Miscellaneous

Free Float
14,794,000
Market Cap
$3.47 million
Optionable
Optionable
Beta
1.13

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ONVO) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners